Systems and methods for mechanogenetic functional ultrasound imaging
US-12172037-B2 · Dec 24, 2024 · US
US2016137707A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016137707-A1 |
| Application number | US-201314786908-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 19, 2013 |
| Priority date | Apr 24, 2013 |
| Publication date | May 19, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a polypeptide containing an extracellular domain of a synaptogenic protein, and a method for manufacturing a nerve cell, a complex containing a biotin tagged at the C-terminus of the polypeptide, an artificial synapse inducer for coupling the composite to a streptavidin (SAV)-coated substrate and a nerve cell. The complex tagged with a biotin at the C-terminus of the polypeptide containing the extracellular domain of the synaptogenic protein, such as neuroligin-1, can display activity by being attached to the SAV-coated substrate to adjust the orientation thereof without help of a supported lipid bilayer. The complex containing an additional RFP between the extracellular domain and the biotin of the synaptogenic protein not only facilitates easier mass-production, quantification, and tracking, but also displays activity of a normal synaptogenic protein, thereby inducing excitatory or inhibitory synaptic differentiation by being fixed to the substrate and added to the nerve cell culture.
Opening claim text (preview).
1 . A complex comprising a polypeptide comprising an extracellular domain of a synaptogenic protein; and biotin tag at the C-terminus of the polypeptide. 2 . The complex of claim 1 , wherein the synaptogenic protein is selected from the group consisting of neuroligin, neurexin, leucine-rich repeat transmembrane protein (LRRTM), netrin G ligand (NGL), synaptic cell adhesion molecule (SynCAM), ephrin-B receptor (EphB), leukocyte common antigen-related protein (LAR), netrin G, and Slitrk (Slit- and Trk-like proteins). 3 . The complex of claim 1 , wherein the synaptogenic protein is neuroligin-1. 4 . The complex of claim 1 , further comprising a fluorescent protein in the order of the polypeptide comprising an extracellular domain of a synaptogenic protein, the fluorescent protein, and the biotin from a N-terminus thereof. 5 . The complex of claim 4 , wherein the fluorescent protein is red fluorescent protein (RFP). 6 . The complex of claim 1 , further comprising a polyhistidine-tag (His-tag) or influenza hemagglutinin epitope tag (HA-tag). 7 . An artificial synapse inducer, wherein the complex of claim 1 is attached to a substrate coated with a biotin-binding protein. 8 . The artificial synapse inducer of claim 7 , wherein the biotin-binding protein is selected from the group of avidin-like proteins consisting of streptavidin, traptavidin, and neutravidin. 9 . The artificial synapse inducer of claim 7 , wherein the substrate is a microbead. 10 . A method for preparing a presynaptic differentiation-induced neuron comprising culturing the neuron in a medium comprising the artificial synapse inducer of claim 7 . 11 . The method of claim 10 , wherein the presynaptic differentiation is an excitatory presynaptic differentiation or an inhibitory presynaptic differentiation. 12 . The artificial synapse inducer of claim 7 , wherein the synaptogenic protein is selected from the group consisting of neuroligin, neurexin, leucine-rich repeat transmembrane protein (LRRTM), netrin G ligand (NGL), synaptic cell adhesion molecule (SynCAM), ephrin-B receptor (EphB), leukocyte common antigen-related protein (LAR), netrin G, and Slitrk (Slit- and Trk-like proteins). 13 . The artificial synapse inducer of claim 7 , wherein the synaptogenic protein is neuroligin-1. 14 . The artificial synapse inducer of claim 7 , wherein the complex further comprises a fluorescent protein in the order of the polypeptide comprising an extracellular domain of a synaptogenic protein, the fluorescent protein, and the biotin from a N-terminus thereof. 15 . The artificial synapse inducer of claim 14 , wherein the fluorescent protein is red fluorescent protein (RFP). 16 . The artificial synapse inducer of claim 7 , wherein the complex further comprises a polyhistidine-tag (His-tag) or influenza hemagglutinin epitope tag (HA-tag).
Receptors; Cell surface antigens; Cell surface determinants {(tumour specific antigens C07K14/4748)} · CPC title
containing a tag for immunodetection, or an epitope for immunisation · CPC title
Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor · CPC title
containing a motif for post-translational modification · CPC title
Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.